has secured NCLT Bengaluru Bench approval for its merger with wholly owned subsidiary Shilpa Therapeutics Private Limited. The tribunal order dated February 27, 2026, sets the appointed date as April 1, 2025, with comprehensive regulatory compliance requirements including settlement of outstanding MSME and statutory dues totaling several crores. The NCLT order approves the amalgamation scheme under Sections 230-232 of the Companies Act, 2013. The tribunal has set the appointed date as April 1, 2025, replacing the originally proposed date of April 1, 2023. Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations.